CVS Health Corporation (ETR: CVS)
Germany
· Delayed Price · Currency is EUR
42.58
+0.34 (0.79%)
Dec 20, 2024, 5:35 PM CET
CVS Health Revenue
CVS Health had revenue of $94.88B USD in the quarter ending September 30, 2024, with 6.02% growth. This brings the company's revenue in the last twelve months to $367.25B, up 5.96% year-over-year. In the year 2023, CVS Health had annual revenue of $356.62B with 10.88% growth.
Revenue (ttm)
$367.25B
Revenue Growth
+5.96%
P/S Ratio
n/a
Revenue / Employee
$1.22M
Employees
300,000
Market Cap
53.59B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 356.62B | 34.99B | 10.88% |
Dec 31, 2022 | 321.63B | 30.72B | 10.56% |
Dec 31, 2021 | 290.91B | 23.00B | 8.59% |
Dec 31, 2020 | 267.91B | 12.14B | 4.75% |
Dec 31, 2019 | 255.77B | 61.85B | 31.89% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCVS Health News
- 2 days ago - Peering Into CVS Health's Recent Short Interest - Benzinga
- 2 days ago - CVS Shares Are Falling Today: What's Going On? - Benzinga
- 2 days ago - CVS Health Corp Expands Aetna Health App with Spanish Language Capabilities - GuruFocus
- 2 days ago - Cramers Mad Dash: CVS Health - CNBC
- 2 days ago - Justice Department Hits CVS With Civil Complaint For Filling 'Unlawful' Prescriptions For Opioids - IBTimes
- 2 days ago - CVS Health (CVS) Faces DOJ Lawsuit Over Opioid Prescription Practices - GuruFocus
- 2 days ago - CVS Faces DOJ Lawsuit Alleging Violations Of Controlled Substances Act And False Claims Act Over Opioid Prescriptions - Benzinga
- 3 days ago - U.S. accuses CVS of unlawfully filling opioid prescriptions - The Washington Post